Table 1.
Haemodynamics, β-adrenoceptor density and noradrenaline concentration, morphology and MAP kinase activation during the progression of HF
| Sham | HF1 | HF2 | HF3 | |
|---|---|---|---|---|
| Heart rate (bpm) | 224 ± 5 | 263 ± 10A | 277 ± 10A | 258 ± 15 |
| LVEDD (mm) | 17.0 ± 0.3 | 18.7 ± 0.4A | 19.3 ± 0.3A | 19.6 ± 0.5AB |
| Fractional shortening (%) | 30.0 ± 1.7 | 19.1 ± 0.7A | 15.9 ± 0.7A | 10.3 ± 1.3AB |
| Noradrenaline (ng·mL−1) | 1.33 ± 0.17 | 2.87 ± 0.69A | 4.03 ± 0.81A | 3.83 ± 0.64A |
| ß-Adrenoceptor density (fmol·mg−1) | 67 ± 5 | 45 ± 2A | 47 ± 2A | 41 ± 3A |
| Cardiomyocyte cross-sectional area (µm2) | 242 ± 11 | 266 ± 4 | 299 ± 8AB | 334 ± 7ABC |
| Number of TUNEL-positive cardiomyocytes [/(1000*mm2)] | 4 ± 2 | 23 ± 5A | 16 ± 4 | 50 ± 8ABC |
| Phospho p38-MAPK/total p38-MAPK (relative to sham) | 1.00 ± 0.24 | 0.54 ± 0.09 | 0.65 ± 0.24 | 2.34 ± 0.54ABC |
| Phospho HSP27/total HSP27 (relative to sham) | 1.00 ± 0.42 | 1.75 ± 0.24 | 1.01 ± 0.14 | 2.58 ± 0.60AC |
Mean ± SEM.
p < 0.05 versus Sham.
p < 0.05 versus HF1.
p < 0.05 versus HF2.
HF1, heart failure rabbits, 1 week (n = 7); HF2, heart failure rabbits, 2 weeks (n = 7); HF3, heart failure rabbits, 3 weeks (n = 8); LVEDD, left ventricular end-diastolic diameter; Sham, sham-operated rabbits (n = 7); TUNEL, TdT-mediated dUTP nick end labelling.